Cognitive Remediation VR Tool for People With MCI: a Feasibility RCT
Cognitive Remediation Virtual Reality Tool a Recovery-oriented Project for People With Mild Cognitive Impairment: a Feasibility Randomized Clinical Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
The need to promote research in active aging trough multidisciplinary and innovative approaches is strongly indicated by the European Union. Our study aims to assess the feasibility and provide a preliminary measure of effectiveness for an intervention using immersive virtual reality (VR) technology for cognitive remediation (CR) in individuals with Mild Cognitive Impairment (MCI)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedStudy Start
First participant enrolled
March 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFebruary 21, 2024
February 1, 2024
9 months
February 13, 2024
February 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Side effects; Dropout rates; Proportion of recruited participants among those considered eligible
Feasibility will be assessed based on tolerability, including dropout rates and acceptability, which considers the proportion of recruited participants among those considered eligible and side effects.
T0 (0 weeks); T1 (12 weeks)
Secondary Outcomes (13)
Short Form Health Survey, 12 items (SF-12)
T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks)
Brief Social Rhythms Scale (BSRS)
T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks)
Patient Health Questionnaire (PHQ-9)
T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks)
Generalized Anxiety Disorder-7 item (GAD-7)
T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks)
Addenbrooke's Cognitive Examination (ACE-R)
T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks)
- +8 more secondary outcomes
Study Arms (2)
Virtual Reality Cognitive Remediation + treatment as usual
EXPERIMENTAL15 Participants with more than 65 years and with MCI diagnosis will undergo a cognitive remediation program using fully immersive VR. Participants will continue with standard care during the experimental intervention
Treatment as usual
NO INTERVENTIONThe control group, 15 participants with more than 65 years and with MCI diagnosis, will continue with standard care.
Interventions
Participants will undergo a 3-months cognitive remediation program using fully immersive VR with two sessions per week. Each session will last a maximum of sixty minutes and will be supervised by expert health professionals. The experimental group participated in an immersive VR-based CR program using the "CEREBRUM" software designed by clinicians and experts specializing in cognitive rehabilitation. CEREBRUM provides 52 exercises: Attention, Working Memory, Memory and Learning and Cognitive Estimates. The intervention included 24 sessions.
Eligibility Criteria
You may qualify if:
- age 65 and above, a diagnosis of MCI based on DSM-IV criteria \[American Psychiatric Association, 2000\]
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Giovanni di Dio Hospital
Cagliari, CA, 09100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 13, 2024
First Posted
February 21, 2024
Study Start
March 7, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
February 21, 2024
Record last verified: 2024-02